Zusammenfassung
Klinisch gebräuchliche Anästhetika besitzen amnestische, sedierende, hypnotische und immobilisierende Eigenschaften. Auf molekularer Ebene modulieren diese Substanzen eine Reihe von Rezeptoren in der Membran von Nervenzellen. Durch Untersuchungen an genetisch veränderten Tieren lässt sich nun erstmals eine Verbindung zwischen den Wirkungen an bestimmten Rezeptoren sowie den daraus resultierenden klinischen Wirkungen und Nebenwirkungen herstellen. So vermittelt ein Subtyp des GABAA-Rezeptors Bewusstseinsverlust und Immobilität; ein anderer Subtyp ist an Sedierung und Hypothermie beteiligt. Diese Erkenntnisse bilden eine Grundlage für die Entwicklung hochspezifischer, nebenwirkungsarmer Medikamente von morgen.
Abtract
Clinically used anesthetics show amnestic, sedative, hypnotic and immobilizing properties. On a molecular level these drugs affect several receptors in the cell membrane of neurons. By using genetically engineered mice a linkage can now be made between actions on certain receptors and clinically desired and undesired effects. Experiments show that a certain GABAA receptor subtype mediates hypnosis and immobility, whereas another subtype is involved in side-effects like sedation and hypothermia. These findings form the basis for the development of new drugs, acting highly specific and with fewer side-effects.
Literatur
Antkowiak B (1999) Different actions of general anaesthetics on the firing patterns of neocortical neurons mediated by the GABAA receptor. Anesthesiology 91:500–511
Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ (1997) The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci USA 94:11031–11036
Belelli D, Pistis M, Peters JA, Lambert JJ (1999) General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci 20:496–502
Blednov YA, Jung S, Alva H, Wallace D, Rosahl T, Whiting PJ, Harris RA (2003) Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs. J Pharmacol Exp Ther 304:30–36
Bohlhalter S, Weinmann O, Mohler H, Fritschy JM (1996) Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 16:283–297
Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M (2001) Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409:88–92
Campagna JA, Miller KW, Forman SA (2003) Mechanisms of actions of inhaled anesthetics. N Engl J Med 348:2110–2124
Cirone J, Rosahl WT, Reynolds DS et al. (2004) Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice. Anesthesiology 100:1438–1445
Downing SS, Lee YT, Farb DH, Gibbs TT (2005) Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABA(A) receptors supports an allosteric model of modulation. Br J Pharmacol 145:894–906
Ernst M, Brauchart D, Boresch S, Sieghart W (2003) Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience 119:933–943
Grasshoff C, Rudolph U, Antkowiak B (2005) Molecular and systemic mechanisms of general anaesthesia: the ‚multi-site and multiple mechanisms‘ concept. Curr Opin Anaesthesiol 18:386–391
Harris BD, Wong G, Moody EJ, Skolnick P (1995) Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors. Mol Pharmacol 47:363–367
Hentschke H, Schwarz C, Antkowiak B (2005) Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABA receptor-mediated inhibition. Eur J Neurosci 21:93–102
Homanics GE, Lorey TM de, Firestone LL et al. (1997) Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 94:4143–4148
Jurd R, Arras M, Lambert S et al. (2003) General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta 3 subunit. FASEB J 17:250–252
Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL (1998) Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that of isoflurane. Mol Pharmacol 53:530–538
Kurz A, Sessler DI, Lenhardt R (1996) Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 334:1209–1215
Lambert S, Arras M, Vogt KE, Rudolph U (2005) Isoflurane-induced surgical tolerance mediated only in part by beta3-containing GABA(A) receptors. Eur J Pharmacol 516:23–27
Li X, Pearce RA (2000) Effects of halothane on GABAA receptor kinetics: evidence for slowed agonist unbinding. J Neurosci 20:899–907
Macdonald R, Barker JL (1978) Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature 271:563–564
Mihic SJ, Ye Q, Wick MJ et al. (1997) Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors. Nature 389:385–389
Mody I, Pearce RA (2004) Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 27:569–575
Möhler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2–8
Otis TS, Mody I (1992) Modulation of decay kinetics and frequency of GABAA receptor-mediated spontaneous inhibitory postsynaptic currents in hippocampal neurons. Neuroscience 49:13–32
Paris A, Philipp M, Tonner PH, Steinfath M, Lohse M, Scholz J, Hein L (2003) Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology 99:889–895
Quinlan JJ, Homanics GE, Firestone LL (1998) Anesthesia sensitivity in mice that lack the β3 subunit of the γ-aminobuyric acid type A receptor. Anesthesiology 88:775–780
Reynolds DS, Rosahl TW, Cirone J et al. (2003) Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J Neurosci 23:8608–8617
Rudolph U, Antkowiak B (2004) Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 5:709–720
Rudolph U, Mohler H (2004) Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 44:475–498
Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A (1996) Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 347:289–292
Siegwart R, Jurd R, Rudolph U (2002) Molecular determinants for the action of general anesthetics at recombinant α2β3γ2 receptors. J Neurochem 80:140–148
Sur C, Wafford KA, Reynolds DS et al. (2001) Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J Neurosci 21:3409–3418
Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D (1984) Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 310:1415–1421
Wallner M, Hanchar HJ, Olsen RW (2003) Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100:15218–15223
Wei W, Faria LC, Mody I (2004) Low ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neurons. J Neurosci 24:8379–8382
Whiting PJ (2003) GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 8:445–450
Wisden W, Gundlach AL, Barnard EA, Seeburg PH, Hunt SP (1991) Distribution of GABAA receptor subunit mRNAs in rat lumbar spinal cord. Brain Res Mol Brain Res 10:179–183
Wong SM, Cheng G, Homanics GE, Kendig JJ (2001) Enflurane actions on spinal cords from mice that lack the β3 subnit of the GABAA receptor. Anesthesiology 95:154–164
Zeller A, Arras M, Lazaris A, Jurd R, Rudolph U (2005) Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB J 19:1677–1679
Interessenkonflikt:
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drexler, B., Grasshoff, C., Rudolph, U. et al. Die GABAA-Rezeptor-Familie. Anaesthesist 55, 287–295 (2006). https://doi.org/10.1007/s00101-005-0950-y
Issue Date:
DOI: https://doi.org/10.1007/s00101-005-0950-y